Table 2.
Time window (TW) | Treatment | Missing\non-evaluable questionnaire | Reason | ||||
---|---|---|---|---|---|---|---|
Present but non-evaluable | Random | QoL related | Dead | Unknown | |||
Baseline | IF (N = 170) | 25 (14.7) | 13 (7.7) | 7 (4.1) | 0 (0.0) | 0 (0.0) | 5 (2.9) |
CF (N = 163) | 20 (12.3) | 7 (4.3) | 12 (7.4) | 0 (0.0) | 0 (0.0) | 1 (0.6) | |
Week 8 | IF (N = 170) | 73 (42.9) | 5 (2.9) | 39 (22.9) | 13 (7.7) | 8 (4.7) | 8 (4.7) |
CF (N = 163) | 84 (51.5) | 6 (3.7) | 52 (31.9) | 8 (4.9) | 7 (4.3) | 11 (6.8) | |
Week 16 | IF (N = 170) | 94 (55.3) | 13 (7.7) | 44 (25.9) | 9 (5.3) | 17 (10.0) | 11 (6.5) |
CF (N = 163) | 106 (65.0) | 9 (5.5) | 49 (30.1) | 13 (8.0) | 23 (14.1) | 12 (7.4) | |
Week 24 | IF (N = 170) | 115 (67.7) | 8 (4.7) | 39 (22.9) | 7 (4.1) | 41 (24.1) | 20 (11.8) |
CF (N = 163) | 128 (78.5) | 13 (8.0) | 37 (22.7) | 8 (4.9) | 52 (31.9) | 18 (11.0) | |
Week 32 | IF (N = 170) | 143 (84.1) | 13 (7.7) | 30 (17.7) | 12 (7.1) | 73 (42.9) | 15 (8.8) |
CF (N = 163) | 137 (84.1) | 10 (6.1) | 29 (17.8) | 9 (5.5) | 75 (46.0) | 14 (8.6) | |
Week 40 | IF (N = 170) | 151 (88.8) | 8 (4.7) | 28 (16.5) | 4 (2.4) | 98 (57.7) | 13 (7.7) |
CF (N = 163) | 152 (93.3) | 9 (5.5) | 31 (19.0) | 7 (4.3) | 99 (60.7) | 6 (3.7) | |
Week 48 | IF (N = 170) | 156 (91.8) | 3 (1.8) | 26 (15.3) | 2 (1.2) | 116 (68.2) | 9 (5.3) |
CF (N = 163) | 160 (98.2) | 3 (1.8) | 40 (24.5) | 3 (1.8) | 110 (67.5) | 4 (2.5) |